The GLIS3 gene helps switch other genes on and off during early development, especially in the pancreas, thyroid, eyes, and kidneys. This gene plays an important role in helping cells that make insulin and thyroid tissue work properly. If the gene does not work well, a person may be born with diabetes, low thyroid hormone levels, and sometimes eye, kidney, or growth problems. GLIS3 is mainly known in medical genetics rather than popular culture.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or regulate processes in the body. Some genes carry the directions for producing proteins, which are the working parts of cells. Others mainly guide when certain processes happen, where they happen, and how active they are. As a group, genes affect how the body develops and works, and they can also influence how you respond to food, stress, and medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
GLIS3Gene function
What if the gene works
The GLIS3 gene helps switch other genes on and off during development. It supports the pancreas, thyroid, eyes, and kidneys, and helps the pancreas make insulin to keep blood sugar in range.
Risk
What if the gene does not work
Variants in the GLIS3 gene can cause diabetes before or soon after birth and low thyroid hormone levels. Some people also have eye, kidney, liver, growth, or developmental differences, with milder or more severe effects.
Treatment
What does that mean for your treatment
No GLIS3-specific treatment or drug selection approach is currently established. Care is based on the features a person has, such as insulin for neonatal diabetes or thyroid hormone for hypothyroidism, rather than the GLIS3 variant itself. Researchers are studying the GLIS3 gene as a biomarker and possible drug target in diabetes and some cancers.
Conditions associated with GLIS3
Gene function
What if the gene works
GLIS3 helps coordinate how certain cells grow, mature, and keep doing their everyday jobs. It mainly works by controlling when other genes are turned on or kept quieter. Understanding what the GLIS3 gene does in the body helps explain its role in the pancreas, thyroid, and other developing tissues.
GLIS3 acts like a control signal for other genes. By attaching to specific stretches of DNA, it helps cells turn selected genes on at the right time and level.
During early growth, the GLIS3 gene helps guide the formation of organs including the pancreas and thyroid. It supports the step by step gene activity that lets these tissues mature in an organized way.
In the pancreas, GLIS3 helps cells that make insulin develop and keep their role. It supports the activity of genes these cells use for normal insulin production and release.
GLIS3 also helps thyroid cells carry out their routine work. It supports gene activity linked to making thyroid hormone, which helps regulate energy use, growth, and temperature control.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help make up normal human diversity, such as variation in appearance, metabolism, or the way the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the GLIS3 gene can alter the protein’s shape, stability, or movement into the cell nucleus, which may weaken how it binds DNA and controls other genes. Some changes only partly reduce activity, while more severe variants can leave little or no working protein. This helps explain how GLIS3 gene variants affect protein function and why GLIS3-related conditions can appear earlier or involve more body systems in some people than in others.
How variants are linked to conditions
Pathogenic variants in the GLIS3 gene can cause a rare condition marked by neonatal diabetes and congenital hypothyroidism, often identified soon after birth. Some people with this GLIS3 gene condition may also have eye, kidney, liver, or growth-related findings. Separately, some common variants in the GLIS3 gene are associated with a higher risk of type 1 diabetes or type 2 diabetes in population studies, but these links do not mean a person will definitely develop diabetes.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and simply reflect natural variation among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences contribute. In some situations, though, one well-defined variant in a particular gene can be enough on its own to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risks related to the GLIS3 gene. In families with a disease-causing GLIS3 change, risk is mainly shaped by the genetic variant itself rather than lifestyle or environmental factors, and a doctor or genetic counselor can explain what that means for relatives.
Inheritance of GLIS3 variants
GLIS3-related conditions are inherited in an autosomal recessive pattern. For families asking how are variants of the GLIS3 gene inherited, this usually means a child needs to inherit one altered copy of the GLIS3 gene from each parent; when both parents are carriers, each pregnancy has a 25% chance of an affected child, a 50% chance of a carrier child, and a 25% chance of a child with two working copies. Because the GLIS3 gene is on one of the numbered chromosomes rather than a sex chromosome, this pattern is the same for boys and girls.
What does my GLIS3 result mean for my family?
For families with a disease-causing GLIS3 result linked to the known GLIS3-related condition, the pattern is usually recessive, which means parents are often healthy carriers and brothers or sisters could also be affected or be carriers. Other close relatives may also carry the change without knowing it, especially on the same side of the family. Family testing can help clarify who else may be at risk of having an affected child.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for variants in the GLIS3 gene usually uses a blood or saliva sample. A lab reads the GLIS3 gene, sometimes along with other genes in a broader panel, to find variants that may help confirm whether this gene is linked to a person’s health condition.
When should I consider getting a genetic test?
Genetic testing for the GLIS3 gene may be worth considering when a baby or child has a rare combination such as diabetes starting very early in life, thyroid problems from birth, and sometimes eye, liver, or kidney issues. It can also help when this pattern runs in the family or a change in GLIS3 is already known in a relative.
A genetic result is only one part of your health story
A genetic result can provide meaningful insight, but how much it reveals depends on the condition and the kind of variant involved. Many factors, including lifestyle, environment, age, and medical history, shape how the body functions over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target, so the same treatment may work better for some people than for others. This is common and can influence both how well a medicine helps and how likely a person is to notice side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect the way they respond to medicines. It studies patterns between genes and drugs to better understand why the same treatment can work differently from one person to another. For many medications, genes influence both how strongly a drug works and how the body handles it. This information can support treatment choices that are better informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the GLIS3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so concerns such as side effects, a new prescription, or changes in your treatment are best discussed with your doctor.
History
GLIS3 entered the genetics literature in the 2000s as researchers studied a small family of related genes involved in early development. Interest grew as scientists linked changes in the GLIS3 gene to rare cases of newborn diabetes and thyroid problems, which helped place it on the clinical genetics map. From these first observations, research expanded steadily. Larger population studies then connected common variants near the GLIS3 gene with risk for type 1 and type 2 diabetes, bringing it into broader research on blood sugar regulation. Over time, the way this gene was viewed shifted from a mainly developmental research target to one with clear medical relevance. Today, GLIS3 is recognized as part of the expanding story of how rare inherited conditions and common disease risk can intersect.